QT Imaging Holdings, Inc. (NASDAQ: QTI) announced on July 28, 2026, that its stockholders approved key governance resolutions at its Annual Meeting of Stockholders. The medical device company, which focuses on radiation-free breast health imaging technology, secured shareholder approval for the election of two Class II directors, the appointment of its independent auditor, and an amendment to its equity incentive plan. These approvals ensure continuity in board leadership and financial oversight for the upcoming fiscal year.

The meeting results were tabulated by an independent inspector of elections. QT Imaging plans to file the official results on Form 8-K with the Securities and Exchange Commission (SEC) today. The procedural filings confirm the formal adoption of the resolutions passed by the shareholders.

Governance and Leadership

Stockholders elected Professor Zeev Weiner and Bryan Timm as Class II directors. Both directors will serve until the Company’s 2029 Annual Meeting of Stockholders or until their respective successors are elected and qualified. This election maintains the staggered board structure, ensuring experienced oversight for the company’s strategic initiatives in medical imaging.

Financial Oversight and Equity Plan

Shareholders appointed BPM LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. This appointment ensures independent audit coverage for the upcoming fiscal period.

Additionally, the stockholders approved an amendment to the Company’s 2024 Equity Incentive Plan. The amendment increases the number of shares authorized and reserved for issuance under the plan, providing greater flexibility for future employee compensation and retention strategies.

Key Resolutions Approved

About QT Imaging Holdings, Inc.

QT Imaging is a public medical device company engaged in the research, development, and commercialization of innovative imaging systems that use low-frequency sound waves. The company strives to improve global health outcomes by providing safe, affordable, and accessible medical imaging solutions centered on the patient’s experience.

QT Imaging Holdings, Inc. CEO Dr. Raluca Dinu presented the Shiftmaker Award to tennis champion Martina Navratilova during a ceremony in London on June 27. The event, part of the Sports Shiftmaker Awards, recognized Navratilova for her achievements in sports and her advocacy for breast health awareness and early detection. QT Imaging served as the presenting partner for the award, underscoring its commitment to advancing women's health through innovative imaging technologies.

The ceremony and subsequent panels were hosted by The Shift, a women's media platform backed by Harvard University and Gloria Steinem. The events brought together leaders from healthcare, investment, and advocacy to discuss the future of women's health. Dr. Dinu emphasized the growing alignment among patients, clinicians, and investors around the need for personalized, patient-centered healthcare solutions.

Following the award ceremony, Dr. Dinu joined Navratilova, biotech investor Kriti Lall of Perceptive Advisors, and journalist Sophia Li for a panel titled "The Paradigm Shift: Redefining the Standard of Care in Women’s Health." The discussion explored how advances in breast health and early detection are transforming outcomes for women. Panelists highlighted the importance of empowering women with information and access to innovative care.

On the same day, Dr. Dinu participated in another panel, "The Era of the Execution Shift for Women’s Health: Scaling Science and Access in Women’s Health." The session focused on innovation in breast cancer and included Susan Wang of T. Rowe Price, Caroline Jefferies of the Center for Research in Women’s Health, and Jaya Rosenmeir of Novartis. The panel was moderated by a journalist from ELLE UK.

Throughout the forums, discussions centered on the convergence of patient advocacy, technological innovation, and investment capital driving progress in women's health. Key topics included breast density awareness, personalized screening approaches, and improving the patient experience. QT Imaging’s participation aligned with its mission to shape the future of breast health through technologies that support more personalized care.

Key Participants and Events

Navratilova, a 59-time Grand Slam titleholder and two-time cancer survivor, was honored for her resilience and advocacy. Her story, Dr. Dinu noted, embodies the themes driving progress in women's health today. The events highlighted the increasing focus on breast health and the need for safe, accessible, and patient-centered imaging technologies.